Gifts in Wills make up over half of our voluntary income so your legacies are vital in helping us achieve our mission.
It can take many years from making a discovery in the lab, to the point at which a new treatment becomes available to patients. It took nearly two decades of dedicated work by ICR scientists and researchers before abiraterone, a prostate drug shown to extend life, was finally approved for use in the UK, US and the rest of Europe.
By supporting us with a gift in your Will, you are investing in the future treatments and preventative strategies that will change the outlook for cancer patients across the world.
Please email the legacy team or call on +44 (0)20 7153 5387 for more information.